Written and medically reviewed by Dorcas Morak, Pharm.D
In 2025, Rite Aid, one of the largest standalone pharmacy chains in the U.S., filed for Chapter 11 bankruptcy protection for the second time in less than two years. The company’s financial struggles reflect deep-seated challenges in the retail pharmacy and healthcare sectors. Major contributing factors included shrinking profit margins on prescription sales, costly legal liabilities related to opioid lawsuits, and stiff competition from larger chains like CVS and Walgreens. Although Rite Aid attempted to reduce its debt burden—closing hundreds of stores and selling assets—the measures were ultimately insufficient to restore profitability.
How Rite Aid’s Bankruptcy Reflects Broader Pharmacy Industry Trends
Rite Aid’s collapse is a clear example of wider disruptions in the pharmacy industry. Chain pharmacies are contending with:
- Reimbursement cuts from Pharmacy Benefit Managers (PBMs), which reduce profits on both generic and brand-name medications. For instance, PBMs may reimburse far less than the cash price for high-volume generics like atorvastatin (Lipitor) or lisinopril.
- Increased consolidation, where large PBMs and insurers favor select chains, leaving mid-size and independent pharmacies at a disadvantage.
- Rising operational costs, including wages, real estate, and tech upgrades, which particularly hurt legacy chains that haven’t modernized quickly.
As a result, pharmacy closures have accelerated nationwide—contributing to the emergence of “pharmacy deserts”, especially in rural and underserved urban areas where access to medication and pharmacist care is already limited.
What Happens to Rite Aid’s Customers and Pharmacy Locations?
To minimize care disruptions, Rite Aid sold many of its pharmacy assets to major competitors including CVS, Walgreens, Albertsons, Kroger, and Giant Eagle. These companies acquired prescription records and locations to ensure continued access for former Rite Aid patients. CVS, in particular, absorbed dozens of Rite Aid locations.
However, hundreds of store closures still reduced the availability of in-person pharmacy services. In many affected regions, particularly in small towns, residents must now travel farther or shift to mail-order and telepharmacy services to obtain medications like metformin for diabetes or amlodipine for hypertension.
Impact of Rite Aid’s Store Closures on Local and Independent Pharmacies
While some independent pharmacies have benefited from increased patient volume due to Rite Aid’s exit, others are struggling to keep up. Independent pharmacies often face:
- Reduced reimbursement rates from PBMs
- Limited negotiating power for wholesale drug prices
- Staffing challenges, particularly in rural communities In states like Pennsylvania—where Rite Aid was headquartered—the closures have created a vacuum. Independent pharmacies must balance the opportunity to serve new customers with the pressure of increased workload, especially for services like medication synchronization, immunizations, or access to specialty drugs like adalimumab (Humira).
What Does Rite Aid’s Bankruptcy Tell Us About the Future Role of Pharmacies?
Pharmacies are shifting from simple dispensing hubs to comprehensive healthcare providers. Services now include:
- Chronic disease management for conditions like asthma, diabetes, and high blood pressure
- Immunization clinics for flu, COVID-19, shingles, and more
- Preventive screenings and basic point-of-care testing
Rite Aid’s bankruptcy illustrates how inflexible business models and overreliance on dispensing revenue can be a liability. The future pharmacy must integrate digital tools, diversify service offerings, and operate efficiently. Innovations like AI-powered medication adherence tools, real-time price transparency, and interoperable pharmacy records will likely define success going forward.
How Can Patients Navigate These Changes and Ensure Access to Affordable Medications?
Patients can take several steps to safeguard access to medications and reduce out-of-pocket costs:
- Track local pharmacy closures and transfer prescriptions promptly to stable providers.
- Use the RxLess® Assurance Plan to compare real-time medication prices across more than 70,000 pharmacies nationwide. For example, cash prices for gabapentin, albuterol, or fluoxetine can vary by as much as 88% depending on the pharmacy.
- Ask about home delivery or 90-day supply discounts - especially for maintenance meds.
- Stay informed about pharmacist services, such as medication therapy management (MTM) or prior authorization support.
- Download the free RxLess® app to access digital savings cards and avoid hidden pharmacy markups.
In a time of significant change, staying proactive is key. Patients who understand their options—especially those using tools like the RxLess® Assurance Plan—are better positioned to save money and maintain uninterrupted access to life-sustaining prescriptions.
